Should Investors Be Worried About Moderna's Leadership Change?

Moderna (NASDAQ: MRNA) recently announced that Tal Zaks, the biotech's chief medical officer, is planning on leaving the company in late September. In this video from Motley Fool Live, recorded on March 1, Fool.com Contributors Brian Orelli and Keith Speights discuss Zaks' history with Moderna and the impact his departure may have on the company's future.

Continue reading

Source Fool.com